| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327694 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
PEG tube placement in ovarian carcinoma is technically feasible and safe in the palliative setting. In addition, PEG tube placement allowed the majority of patients to have end-of-life care either at home or in an inpatient hospice. For the total population, no benefit was seen regarding survival with the use of TPN in this setting. Selected patients (younger age and without liver metastasis) may benefit from chemotherapy after PEG tube placement.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bhavana Pothuri, Michelle Montemarano, Melissa Gerardi, Moshe Shike, Leah Ben-Porat, Paul Sabbatini, Richard R. Barakat,